Jeong, D.W., Lee, S., and Chun, Y.S., How cancer cells remodel lipid metabolism: Strategies targeting transcription factors, Lipids Health Dis., 2021, vol. 20, no. 1, p. 163. https://doi.org/10.1186/s12944-021-01593-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liberti, M.V. and Locasale, J.W., The Warburg effect: How does it benefit Cancer cells?, Trends Biochem Sci., 2016, vol. 41, no. 3, pp. 211–218. https://doi.org/10.1016/j.tibs.2015.12.001

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cluntun, A.A., Lukey, M.J., Cerione, R.A., and Locasale, J.W., Glutamine metabolism in cancer: Understanding the heterogeneity, Trends Cancer, 2017, vol. 3, no. 3, pp. 169–180. https://doi.org/10.1016/j.trecan.2017.01.005

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nassar, A.F., Nie, X., Zhang, T., Yeung, J., Norris, P., He, J., et al., Is lipid metabolism of value in cancer research and treatment? Part I. Lipid metabolism in cancer, Metabolites, 2024, vol. 14, no. 6, p. 312. https://doi.org/10.3390/metabo14060312

Article  CAS  PubMed  PubMed Central  Google Scholar 

Matsushita, Y., Nakagawa, H., and Koike, K., Lipid metabolism in oncology: Why it matters, how to research, and how to treat, Cancers, 2021, vol. 13, no. 3, p. 474. https://doi.org/10.3390/cancers13030474

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheng, H., Wang, M., Su, J., Li, Y., Long, J., Chu, J., et al., Lipid metabolism and cancer, Life, 2022, vol. 12, no. 6, p. 784. https://doi.org/10.3390/life12060784

Guo, R., Chen, Y., Borgard, H., Jijiwa, M., Nasu, M., He, M., et al., The function and mechanism of lipid molecules and their roles in the diagnosis and prognosis of breast cancer, Molecules, 2020, vol. 25, p. 4864. https://doi.org/10.3390/molecules25204864

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang, X., Liu, B., and Shen, S., Lipid metabolism in breast cancer: From basic research to clinical application, Cancers, 2025, vol. 17, no. 4, p. 650. https://doi.org/10.3390/cancers17040650

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang, L., Cui, X., Zhang, N., Li, M., Bai, Y., Han, X., et al., Comprehensive lipid profiling of plasma in patients with benign breast tumor and breast cancer reveals novel biomarkers, Anal. Bioanal. Chem., 2015, vol. 407, pp. 5065–5077. https://doi.org/10.1007/s00216-015-8484-x

Article  CAS  PubMed  Google Scholar 

Hammad, L.A., Wu, G., Saleh, M.M., Klouckova, I., Dobrolecki, L.E., Hickey, R.J., et al., Elevated levels of hydroxylated phosphocholine lipids in the blood serum of breast cancer patients, Rapid Commun. Mass Spectrom., 2009, vol. 23, pp. 863–876. https://doi.org/10.1002/rcm.3947

Article  CAS  PubMed  Google Scholar 

Min, H.K., Kong, G., and Moon, M.H., Quantitative analysis of urinary phospholipids found in patients with breast cancer by nanoflow liquid chromatography-tandem mass spectrometry: II. Negative ion mode analysis of four phospholipid classes, Anal. Bioanal. Chem., 2010, vol. 396, pp. 1273–1280.  https://doi.org/10.1007/s00216-009-3292-9

Article  CAS  PubMed  Google Scholar 

Chen, X., Chen, H., Dai, M., Ai, J., Li, Y., Mahon, B., et al., Plasma lipidomics profiling identified lipid biomarkers in distinguishing early-stage breast cancer from benign lesions, Oncotarget, 2016, vol. 7, pp. 36622–36631. https://doi.org/10.18632/oncotarget.9124

Article  PubMed  PubMed Central  Google Scholar 

Oresic, M., Hanninen, V.A., and Vidal-Puig, A., Lipidomics: A new window to biomedical frontiers, Trends Biotechnol., 2008, vol. 26, pp. 647–652. https://doi.org/10.1016/j.tibtech.2008.09.001

Article  CAS  PubMed  Google Scholar 

Hosokawa, Y., Masaki, N., Takei, S., Horikawa, M., Matsushita, S., Sugiyama, E., et al., Recurrent triple-negative breast cancer (TNBC) tissues contain a higher amount of phosphatidylcholine (32:1) than non-recurrent TNBC tissues, PLoS One, 2017, vol. 12, p. e0183724. https://doi.org/10.1371/journal.pone.0183724

Article  CAS  PubMed  PubMed Central  Google Scholar 

Park, J., Shin, Y., Kim, T.H., Kim, D.H., and Lee, A., Plasma metabolites as possible biomarkers for diagnosis of breast cancer, PLoS One, 2019, vol. 14, p. e0225129. https://doi.org/10.1371/journal.pone.0225129

Article  CAS  PubMed  PubMed Central  Google Scholar 

Takanashi, Y., Kahyo, T., Sekihara, K., Kawase, A., Setou, M., and Funai, K., Prognostic potential of lipid profiling in cancer patients: A systematic review of mass spectrometry-based studies, Lipids Health Dis., 2024, vol. 23, no. 1, p. 154. https://doi.org/10.1186/s12944-024-02121-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim, H.Y., Lee, K.M., Kim, S.H., Kwon, Y.J., Chun, Y.J., and Choi, H.K., Comparative metabolic and lipidomic profiling of human breast cancer cells with different metastatic potentials, Oncotarget, 2016, vol. 7, no. 41, pp. 67111–67128. https://doi.org/10.18632/oncotarget.11560

Article  PubMed  PubMed Central  Google Scholar 

Beloribi-Djefaflia, S., Vasseur, S., and Guillaumond, F., Lipid metabolic reprogramming in cancer cells, Oncogenesis, 2016, vol. 5, no. 1, p. e189. https://doi.org/10.1038/oncsis.2015.49

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gustbee, E., Tryggvadottir, H., Markkula, A., Simonsson, M., Nodin, B., Jirstrom, K., et al., Tumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients, BMC Clin. Pathol., 2015, vol. 15, no. 1, p. 8. https://doi.org/10.1186/s12907-015-0008-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Singhai, H., Rathee, S., and Patil, U.K., Lipidomics in breast cancer: Decoding metabolic reprogramming and unlocking therapeutic opportunities, Curr. Drug Targets, 2025, vol. 26, no. 11, pp. 770–778. https://doi.org/10.2174/0113894501387287250611095023

Article  CAS  PubMed  Google Scholar 

Cai, X.X., Zhang, Z.Z., Yang, X.X., Shen, W.R., Yuan, L.W., Ding, X., et al., Unveiling the impact of lipid metabolism on triple-negative breast cancer growth and treatment options, Front. Oncol., 2025, vol. 15, p. 1579423. https://doi.org/10.3389/fonc.2025.1579423

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ahern, T.P., Pedersen, L., Tarp, M., Cronin-Fenton, D.P., Garne, J.P., Silliman, R.A., et al., Statin prescriptions and breast cancer recurrence risk: A Danish nationwide prospective cohort study, J. Natl. Cancer Inst., 2011, vol. 103, no. 19, pp. 1461–1468. https://doi.org/10.1093/jnci/djr291

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang, L.-H., Chung, H.-Y., and Su, H.-M., Docosahexaenoic acid reduces sterol regulatory element binding protein-1 and fatty acid synthase expression and inhibits cell proliferation by inhibiting pAkt signaling in a human breast cancer MCF-7 cell line, BMC Cancer, 2017, vol. 17, no. 1, p. 890.  https://doi.org/10.1186/s12885-017-3936-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Witte, T.R. and Hardman, W.E., The effects of omega-3 polyunsaturated fatty acid consumption on mammary carcinogenesis, Lipids, 2015, vol. 50, no. 5, pp. 437–446. https://doi.org/10.1007/s11745-015-4011-2

Article  CAS  PubMed  Google Scholar 

Nindrea, R.D., Aryandono, T., Lazuardi, L., and Dwiprahasto, I., Protective effect of omega-3 fatty acids in fish consumption against breast cancer in Asian patients: A meta-analysis, Asian Pac. J. Cancer Prev., 2019, vol. 20, no. 2, pp. 327–332. https://doi.org/10.31557/APJCP.2019.20.2.327

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang, Y., Hsu, J.M., Sun, L., Chan, L.C., Li, C.W., Hsu, J.L., et al., Palmitoylation stabilizes PD-L1 to promote breast tumor growth, Cell Res., 2019, vol. 29, no. 1, pp. 83–86. https://doi.org/10.1038/s41422-018-0124-5

Article